Skip to content

TransThera Sciences (Nanjing) Inc Sustainability Reports

TransThera Sciences (Nanjing), Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapies for oncology, inflammatory, and cardiometabolic diseases.

Sector: Manufacturing

Country: China

Exchange: Hong Kong Stock Exchange

LEI: 836800110GC58JARGW44

FIGI: BBG01VJPCK51

2 reports from 2025 to 2025